Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM PAR NO PAR
-
Total 13F shares
-
6,958,807
-
Share change
-
+286,290
-
Total reported value
-
$106,896,000
-
Price per share
-
$15.29
-
Number of holders
-
28
-
Value change
-
+$4,389,795
-
Number of buys
-
11
-
Number of sells
-
12
Institutional Holders of CYNAPSUS THERAPEUTICS INC - COM PAR NO PAR (CYNA) as of Q4 2015
As of 31 Dec 2015,
CYNAPSUS THERAPEUTICS INC - COM PAR NO PAR (CYNA) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,958,807 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, Aisling Capital LLC, ADAGE CAPITAL PARTNERS GP LLC, Broadfin Capital, LLC, ACUTA CAPITAL PARTNERS, LLC, First Light Asset Management, LLC, MILLENNIUM MANAGEMENT LLC, PURA VIDA INVESTMENTS, LLC, and Tekla Capital Management LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.